Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 4101-4110 of 11985

Page
per page
  1. AES-135
    BA4151 AES-135
    Summary: AES-135, a hydroxamic acid-based pan-inhibitor, prolongs survival in an in situ mouse model of pancreatic cancer.
  2. TFA-Gly-OH
    BA9493 TFA-Gly-OH
    Summary: A glycine derivative.
  3. LPA2 antagonist 2
    C8538 LPA2 antagonist 2
  4. K-Ras(G12C) inhibitor 12
    B4876 K-Ras(G12C) inhibitor 12
    Summary: allosteric inhibitor of K-Ras(G12C)
      ≥8.98 mg/mL
  5. Oleandomycin
    C3213 Oleandomycin
    Summary: macrolide antibiotic
      Soluble in DMSO
  6. p-iodo-Clonidine (hydrochloride)
    C5822 p-iodo-Clonidine (hydrochloride)
    Summary: partial agonist of the α2-adrenergic receptor
      ≤1 mg/mL
  7. Bromhexine HCl
    B1899 Bromhexine HCl
    Summary: bronchial mucolytic agent
  8. Rebamipide
    B2018 Rebamipide
    Summary: cholecystokinin type 1 (CCK1) receptor inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.25 mg/mL
  9. 5-Aminolevulinic acid HCl
    B2070 5-Aminolevulinic acid HCl
    Summary: photosensitizing agent， antineoplastic agent
      insoluble in EtOH; ≥111.4 mg/mL
  10. Nefazodone hydrochloride
    B7183 Nefazodone hydrochloride
    Summary: 5-HT2A receptor antagonist
      ≥26.7 mg/mL

Items 4101-4110 of 11985

Page
per page